drugset / Trial / NCT03019991
Safety, Tolerability and Pharmacokinetics of Danoprevir/r in Healthy Volunteers China
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the Pharmacokinetics of Danoprevir in single dose (100mg QD on day 1, day 4 and day 14) and Ritonavir-boosted Danoprevir (100mg QD on day 4 and day 14) in single and multiple doses (100mg BID on day 5 -day 13) in healthy volunteers.
Timeline
- Start
- 2015-10
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | danoprevir | Small molecule | 100 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | Oral |
Indications
No indication recorded.